Hamdan Medical Journal (previously the Journal of Medical Sciences)

Table of Contents  

The Genetic Research Cycle in Human Disease: The Huntington's Disease Paradigm

James F Gusella
Published in : Journal of Medical Sciences ; Vol 2, No 1 (2009)
DOI : 10.2174/1996327000902010029

Abstract


For more than a century after the description of Huntington's Disease (HD), an inherited neurodegenerative disorder, by George Huntington, a physician on Long Island New York, research into the affliction concentrated on clinical and neuropathological correlates, trying to work backwards from these phenotypes to crucial steps earlier in the disease pathway. These efforts provided excellent clinical and pathological descriptions, and supplied chemical models in rodents, but working backwards from the ultimate disease phenotype did not identify definitive, causative biochemical steps in the disease process or provide a rational route to an effective therapy. In 1983, an alternative approach emerged, aimed at studying pathogenesis from its starting point, the HD gene, rather than from its endpoint, neuronal dysfunction and loss. This paradigm, which I term the Genetic Research Cycle, has acted as a model for similar investigations in a wide range of neurological disorders, leading to better diagnosis and patient management, deeper understanding of pathogenesis, and routes for developing rational, effective treatments.

View article in  :   PDF    

References


Gusella JF, McNeil S, Persichetti F, et al. Huntington's disease. Cold Spring Harb Symp Quant Biol 1996; 61: 615-26.

Gusella JF, Wexler NS, Conneally PMet al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983; 306(5940): 234-8.

Gusella JF. Genetic linkage of the Huntington's disease gene to a DNA marker. Can J Neurol Sci 1984; 11(4): 421-5.

Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group. Cell 1993; 72(6): 971-83.

Gusella JF, MacDonald ME. Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci 2000; 1(2): 109-15. Review.

Myers RH, Leavitt J, Farrer LA, et al. Homozygote for Huntington disease. Am J Hum Genet 1989; 45(4): 615-8.

Gusella J, MacDonald M. No post-genetics era in human disease research. Nat Rev Genet 2002; 3(1): 72-9.

Scherzinger E, Lurz R, Turmaine M, et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell. 1997; 90(3): 549-58.

Huang CC, Faber PW, Persichetti F, et al. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat Cell Mol Genet 1998; 24(4): 217-33.





Add comment 





Home  Editorial Board  Search  Current Issue  Archive Issues  Announcements  Aims & Scope  About the Journal  How to Submit  Contact Us
Find out how to become a part of the HMJ  |   CLICK HERE >>
© Copyright 2012 - 2013 HMJ - HAMDAN Medical Journal. All Rights Reserved         Website Developed By Cedar Solutions INDIA